戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 n, or disease-free survival in patients with papillary cancer.
2 ents enrolled between 2007 and 2010; 92% had papillary cancer.
3       Most patients (1541 of 1885 [82%]) had papillary cancer.
4 ntly due to the increased detection of small papillary cancers.
5 s had benign and 71 had malignant tumors (58 papillary cancers, 10 follicular cancers, 1 Hurthle cell
6 December 2021 was approximately 10 200: 5400 papillary cancers 2 cm or smaller (95% CI, 2380-8530), 3
7 ence of thyroid cancers decreased by 11% for papillary cancers 2 cm or smaller (risk ratio [RR], 0.89
8                   Histopathology included 88 papillary cancers, 7 follicular cancers, and 4 Hurthle c
9 dine-131 was given to 85.4% of patients with papillary cancer and 79.3% of patients with follicular c
10  improvement in progression in patients with papillary cancer and improvement in progression and dise
11   This novel isoform was present in both the papillary cancers and contralateral tissues.
12                    Several isoforms found in papillary cancers are not detectable in histologically n
13               These were predominantly small papillary cancers but also affected all histologic types
14 al Akt were identified in follicular but not papillary cancers compared with normal tissue.
15                                              Papillary cancers in younger children were histologicall
16 rs 2 cm or smaller (95% CI, 2380-8530), 3700 papillary cancers larger than 2 cm (95% CI, 1660-5810),
17 atio [RR], 0.89; 95% CI, 0.83-0.95), 14% for papillary cancers larger than 2 cm (RR, 0.86; 95% CI, 0.
18 pillary thyroid cancers presenting as occult papillary cancers (<1 cm) and as a dominant nodule had s
19 s (i.e., low grade clear cell carcinomas and papillary cancers), normal cadherin-6 expression was pre
20 re reported for all participants, those with papillary cancer only, and women only.
21                                      Thyroid papillary cancers (PTCs) are associated with activating
22                             In patients with papillary cancer, radioiodine therapy was associated wit
23           In addition to well-differentiated papillary cancer, STRN-ALK was found with a higher preva
24          Therefore, as with hereditary renal papillary cancer, the mutant Met allele may also be sele